Evidence map›Paper›PMID 41901206›Full record

ArticlePharmaceuticals (Basel, Switzerland)2026

Yixinjiedu Formula Attenuates Pressure Overload-Induced Cardiac Dysfunction by Suppressing Ferroptosis and Restoring Mitophagy via the PINK1/Parkin Axis.

Kang Xie, Haowen Zhuang, Xin Dong, Yulin Ouyang, Xin Liu, Zhongzheng Zhang, Mengyuan Wang, Jinhong Chen, Xinmeng Teng, Wei Wang and 2 more

Abstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Kang XieSchool of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou 510006, China.ORCID 0009-0009-1390-1565
Haowen ZhuangThe First Affiliated Hospital, Guangzhou University of Chinese Medicine, Guangzhou 510405, China.ORCID 0009-0002-2484-4235
Xin DongThe First Affiliated Hospital, Guangzhou University of Chinese Medicine, Guangzhou 510405, China.
Yulin OuyangSchool of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou 510006, China.ORCID 0009-0000-4697-2647
Xin LiuGuangdong Provincial Key Laboratory of Syndrome and Formula, School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou 510006, China.
Zhongzheng ZhangSchool of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou 510006, China.
Mengyuan WangSchool of Basic Medical Sciences, Guangzhou University of Chinese Medicine, Guangzhou 510006, China.
Jinhong ChenSchool of Basic Medical Sciences, Guangzhou University of Chinese Medicine, Guangzhou 510006, China.ORCID 0009-0001-8665-1351
Xinmeng TengSchool of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou 510006, China.
Wei WangState Key Laboratory of Traditional Chinese Medicine Syndrome, School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou 510006, China.
Chun LiState Key Laboratory of Traditional Chinese Medicine Syndrome, School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou 510006, China.
Junyan WangSchool of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou 510006, China.ORCID 0000-0002-2048-2225

Funding

Guangdong Provincial Key Laboratory of Syndrome and Formula 2022B1212010012Incubation Program for the Science and Technology Development of Chinese Medicine Guangdong Laboratory HQCML-C-2024003Incubation Program for the Science and Technology Development of Chinese Medicine Guangdong Laboratory HQL2024PZ045National Key Research and Development Program of China 2022YFC3500100National Natural Science Foundation of China 82230126National Natural Science Foundation of China U24A20800National Science and Technology Major Project of the Ministry of Science and Technology of China 2023ZD0502600National Science Fund for Excellent Young Scholars 82222075National TCM Heritage and Innovation Team Project ZYYCXTD-C-202201
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ferroptosisheart failuremitophagyPINK1/Parkin pathwayYixinjiedu formula

Identifiers

PMID41901206
PMCPMC13028673

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.